- Home
- CRGO vs MCRB Comparison
CRGO vs MCRB Comparison
Compare CRGO & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGO
- MCRB
- Stock Information
- Founded
- CRGO 2012
- MCRB 2010
- Country
- CRGO Spain
- MCRB United States
- Employees
- CRGO N/A
- MCRB N/A
- Industry
- CRGO Blank Checks
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- CRGO Finance
- MCRB Health Care
- Exchange
- CRGO Nasdaq
- MCRB Nasdaq
- Market Cap
- CRGO 165.6M
- MCRB 144.6M
- IPO Year
- CRGO N/A
- MCRB 2015
- Fundamental
- Price
- CRGO $3.66
- MCRB $19.64
- Analyst Decision
- CRGO
- MCRB Hold
- Analyst Count
- CRGO 0
- MCRB 4
- Target Price
- CRGO N/A
- MCRB $14.33
- AVG Volume (30 Days)
- CRGO 100.5K
- MCRB 178.9K
- Earning Date
- CRGO 11-24-2025
- MCRB 11-12-2025
- Dividend Yield
- CRGO N/A
- MCRB N/A
- EPS Growth
- CRGO N/A
- MCRB N/A
- EPS
- CRGO N/A
- MCRB 10.22
- Revenue
- CRGO $27,155,000.00
- MCRB N/A
- Revenue This Year
- CRGO $27.56
- MCRB N/A
- Revenue Next Year
- CRGO $24.45
- MCRB N/A
- P/E Ratio
- CRGO N/A
- MCRB $1.92
- Revenue Growth
- CRGO 27.02
- MCRB N/A
- 52 Week Low
- CRGO $1.27
- MCRB $6.53
- 52 Week High
- CRGO $4.42
- MCRB $24.67
- Technical
- Relative Strength Index (RSI)
- CRGO 58.97
- MCRB 56.40
- Support Level
- CRGO $3.16
- MCRB $19.14
- Resistance Level
- CRGO $3.66
- MCRB $21.50
- Average True Range (ATR)
- CRGO 0.19
- MCRB 1.46
- MACD
- CRGO 0.02
- MCRB 0.13
- Stochastic Oscillator
- CRGO 65.06
- MCRB 69.59
About CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.